SCHEMBL413201

SCHEMBL413201

CC1=Cc2cc3c(cc2C1)CCC3

nearest known ligand 0.31

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
GRIN2B Q13224 1/20 0.30
GRIN2C Q14957 1/20 0.30
GRIN3A Q8TCU5 1/20 0.30
RAPGEF4 Q8WZA2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29534955 1.00 NPC1 (0.31) NPC1RAB9AGRIN2DGRIN3BGRIN1
SCHEMBL5716873 0.96 TSHR (0.33)
SCHEMBL409885 0.86
SCHEMBL2865299 0.76 DRD2 (0.30)
SCHEMBL18009559 0.75
SCHEMBL2782866 0.75 NPC1 (0.34) NPC1RAB9A
SCHEMBL23753569 0.74 GRIN2D (0.30) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL25748393 0.74
SCHEMBL30402757 0.74 GRIN2D (0.30) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28911520 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101707-A1 JULOLIDINE SUBSTITUTED METALLOCENE CATALYSTS ExxonMobil Technology and Engineering Company (US) 2026-05-15 WO disclosed
US-12195563-B2 Polyolefin-based ionomers and production thereof EXXONMOBIL CHEMICAL PATENTS INC. (US) 2025-01-14 US disclosed
US-20240084056-A1 Polyolefin-Based Ionomers and Production Thereof EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-03-14 US disclosed
EP-4271718-A1 POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF ExxonMobil Chemical Patents Inc. (US) 2023-11-08 EP disclosed
CN-116670188-A Polyolefin-based ionomers and preparation thereof 埃克森美孚化学专利公司 2023-08-29 CN disclosed
US-20220213241-A1 Polyolefin-Based Ionomers and Production Thereof EXXONMOBIL CHEMICAL PATENTS INC (US) 2022-07-07 US disclosed
WO-2022146634-A1 POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-07-07 WO disclosed
US-20160122925-A1 CUSHIONING MATERIALS COMPRISING ETHYLENE/ALPHA-OLEFIN COPOLYMER BLENDS DOW GLOBAL TECHNOLOGIES LLC 2016-05-05 US disclosed
EP-2222720-B1 MONO-HYDROINDACENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2016-02-10 EP disclosed
US-8722832-B2 Ethylene terpolymers BASELL POLYOLEFINE GMBH (DE) 2014-05-13 US disclosed
EP-2245076-A1 ETHYLENE TERPOLYMERS Basell Polyolefine GmbH (DE) 2010-11-03 EP disclosed
US-20100267901-A1 PROCESS FOR OBTAINING POLYMERS OF ETHYLENE AND CYCLOOLEFINS BASELL POLYOLEFINE GMBH (DE) 2010-10-21 US disclosed
US-20100249346-A1 METALLOCENE COMPOUNDS BASED ON ETHANEDIYL-BRIDGED INDENE AND CYCLOPENTADITHIOPHENE LIGANDS BASELL POLYOLEFINE GMBH (DE) 2010-09-30 US disclosed
EP-2227493-A1 PROCESS FOR OBTAINING POLYMERS OF ETHYLENE AND CYCLOOLEFINS Basell Polyolefine GmbH (DE) 2010-09-15 EP disclosed
EP-2222720-A1 MONO-HYDROINDACENYL COMPLEXES Basell Polyolefine GmbH (DE) 2010-09-01 EP disclosed
EP-2197871-A1 METALLOCENE COMPOUNDS BASED ON ETHANEDIYL-BRIDGED INDENE AND CYCLOPENTADITHIOPHENE LIGANDS Basell Polyolefine GmbH (DE) 2010-06-23 EP disclosed
WO-2009080216-A1 MONO-HYDROINDACENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2009-07-02 WO disclosed
WO-2009080174-A1 ETHYLENE TERPOLYMERS BASELL POLYOLEFINE GMBH (DE) 2009-07-02 WO disclosed
WO-2009080438-A1 PROCESS FOR OBTAINING POLYMERS OF ETHYLENE AND CYCLOOLEFINS BASELL POLYOLEFINE GMBH (DE) 2009-07-02 WO disclosed
WO-2009050037-A1 METALLOCENE COMPOUNDS BASED ON ETHANEDIYL-BRIDGED INDENE AND CYCLOPENTADITHIOPHENE LIGANDS BASELL POLYOLEFINE GMBH (DE) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249346-A1 METALLOCENE COMPOUNDS BASED ON ETHANEDIYL-BRIDGED INDENE AND CYCLOPENTADITHIOPHENE LIGANDS CHRM1, CCNT1, CYC1 NPC1 2878/4885RAB9A 2068/4885GRIN2D 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.